Celltrion Biopharmaceutical Plant, Incheon

The new facility will start production with therapeutic monoclonal antibodies as a custom manufacturing facility for third parties.

The new facility will start production with therapeutic monoclonal antibodies as a custom manufacturing facility for third parties.


client logon
Home
Products & Services
Company A-Z
White Papers
Jobs & Careers
Press Releases
Advertise With Us
Events & Exhibitions
Newsletter
New On This Site
About Us
Atom FeedRSS Feed
What is RSS?